nitrendipine has been researched along with Adenoma, Basal Cell in 6 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The chronic effect of the calcium antagonist nitrendipine was investigated on blood pressure (BP), plasma aldosterone concentration (PAC), plasma renin activity (PRA), and serum potassium in six patients with primary aldosteronism, either due to an (unilateral) aldosterone-producing adenoma (APA; n = 3; age, 44 +/- 4 years; PAC, 312 +/- 96 pg/ml; PRA, less than 0." | 5.06 | Therapeutic value of calcium antagonists in autonomous hyperaldosteronism. ( Ivens, K; Kaufmann, W; Stimpel, M; Volkmann, HP; Wambach, G, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishina, Y | 1 |
| Takano, K | 3 |
| Yasufuku-Takano, J | 2 |
| Teramoto, A | 3 |
| Fujita, T | 2 |
| Jacobs, U | 1 |
| Klein, B | 1 |
| Klehr, HU | 1 |
| Takei, T | 1 |
| Yamashita, N | 3 |
| Kojima, I | 1 |
| Kitaoka, M | 1 |
| Ogata, E | 2 |
| Matsunaga, H | 1 |
| Shibuya, N | 1 |
| Takakura, K | 1 |
| Stimpel, M | 1 |
| Ivens, K | 1 |
| Volkmann, HP | 1 |
| Wambach, G | 1 |
| Kaufmann, W | 1 |
1 trial available for nitrendipine and Adenoma, Basal Cell
| Article | Year |
|---|---|
Therapeutic value of calcium antagonists in autonomous hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Blood Pressure; Clinical Trials as Topic; Fema | 1989 |
5 other studies available for nitrendipine and Adenoma, Basal Cell
| Article | Year |
|---|---|
Mechanism of D(2) agonist-induced inhibition of GH secretion from human GH-secreting adenoma cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenoma; Bromocriptine; Calcium; Calcium Channels; Dopamine | 2005 |
Cumulative side effects of cyclosporine and Ca antagonists: hypergalactinemia, mastadenoma, and gynecomastia.
Topics: Adenoma; Adult; Aged; Breast Neoplasms, Male; Calcium Channel Blockers; Cyclosporine; Diltiazem; Dru | 1994 |
Effect of Ca2+ and cAMP on capacitance-measured hormone secretion in human GH-secreting adenoma cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenoma; Calcium; Calcium Channels; Cyclic AMP; Exocytosis; | 1998 |
Effects of activin A and somatostatin on intact FSH secretion and intracellular Ca2+ concentration in human FSH-secreting pituitary adenoma cells.
Topics: Activins; Adenoma; Calcium; Dose-Response Relationship, Drug; Follicle Stimulating Hormone; Humans; | 1992 |
Two types of calcium channels and hormone release in human pituitary tumor cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1988 |